Literature DB >> 10958237

Hypercalcemia in granulomatous disorders: a clinical review.

O P Sharma1.   

Abstract

Hypercalcemia occurs in most granulomatous disorders. High serum calcium levels are seen in about 10% of patients with sarcoidosis; hypercalciuria is about three times more frequent. Tuberculosis, fungal granulomas, berylliosis, and lymphomas are other conditions that are associated with disorders of calcium metabolism. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH2)D3 (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroquine, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958237     DOI: 10.1097/00063198-200009000-00010

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  56 in total

1.  Concomitant sarcoidosis and papillary thyroid cancer with severe hypercalcaemia as the main symptom.

Authors:  Mikael Groth Riis; Kasper Svendsen Juhl; Jens Meldgaard Bruun
Journal:  BMJ Case Rep       Date:  2018-06-08

2.  Hypercalcaemia: atypical presentation of miliary tuberculosis.

Authors:  Edison So; Dennis Thomas Bolger
Journal:  BMJ Case Rep       Date:  2014-02-25

3.  [Disorders of calcium metabolism].

Authors:  C Kasperk; H Bartl
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

4.  Diagnosing the Treatment.

Authors:  Sarah A McGuffin; Robert L Trowbridge; Ann M O'Hare; Andrew P Olson
Journal:  J Hosp Med       Date:  2018-06-27       Impact factor: 2.960

Review 5.  ASIA syndrome, calcinosis cutis and chronic kidney disease following silicone injections. A case-based review.

Authors:  Giuseppe Barilaro; Claudia Spaziani Testa; Antonella Cacciani; Giuseppe Donato; Mira Dimko; Amalia Mariotti
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

6.  [Renal manifestations in rheumatic diseases].

Authors:  K de Groot
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

7.  [Hypercalcemic crisis].

Authors:  J Pfeilschifter
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

8.  Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis.

Authors:  P Selvaraj; S Prabhu Anand; M Harishankar; K Alagarasu
Journal:  J Clin Immunol       Date:  2009-02-14       Impact factor: 8.317

9.  A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for Wasting.

Authors:  Sahar M Hindi; Yongmei Wang; Kirk D Jones; Jesse C Nussbaum; Yongen Chang; Umesh Masharani; Daniel Bikle; Dolores M Shoback; Edward C Hsiao
Journal:  Calcif Tissue Int       Date:  2015-08-08       Impact factor: 4.333

10.  Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis.

Authors:  G Chandra; P Selvaraj; M S Jawahar; V V Banurekha; P R Narayanan
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.